Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

BI-2536 shows potential in models of osteosarcoma

Jan. 27, 2011

AMG-386 does not improve efficacy of CX combination in gastroesophageal adenocarcinoma

Jan. 27, 2011

AZD-0530 suppresses migration of biliary cancer cells in vitro

Jan. 26, 2011

Researchers induce bone repair via "same day" ex vivo regional gene therapy in rats

Jan. 26, 2011

Mapatumumab/sorafenib combination is safe in patients with advanced HCC and chronic hepatitis

Jan. 26, 2011

Recombinant PDGF-BB shows promise in tendinopathy and osteochondral defect repair

Jan. 26, 2011

Flex-590 confers chondroprotection in a model of osteoarthritis

Jan. 25, 2011

Phase I data reported on recombinant angiotensin-converting enzyme 2

Jan. 25, 2011

StronBone Sr-substituted bioactive glass implants show promise in bone grafting

Jan. 25, 2011

Interim phase II data disclosed on nimotuzumab plus irinotecan in gastric cancer

Jan. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...